149 related articles for article (PubMed ID: 30994215)
1. Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes.
Ganster C; Müller-Thomas C; Haferlach C; Strupp C; Ogata K; Germing U; Hildebrandt B; Mallo M; Lübbert M; Müller C; Solé F; Götze KS; Vandenberghe P; Göhring G; Steinmetz T; Kröger N; Platzbecker U; Söling U; Raynaud S; Shirneshan K; Schanz J; Haase D
Genes Chromosomes Cancer; 2019 Oct; 58(10):689-697. PubMed ID: 30994215
[TBL] [Abstract][Full Text] [Related]
2. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
Slovak ML; O'Donnell M; Smith DD; Gaal K
Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
[TBL] [Abstract][Full Text] [Related]
3. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation.
Itonaga H; Ishiyama K; Aoki K; Aoki J; Ishikawa T; Ohashi K; Fukuda T; Ozawa Y; Ota S; Uchida N; Eto T; Iwato K; Ohno Y; Takanashi M; Ichinohe T; Atsuta Y; Miyazaki Y
Bone Marrow Transplant; 2019 Sep; 54(9):1471-1481. PubMed ID: 30718803
[TBL] [Abstract][Full Text] [Related]
5. Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.
Cordoba I; González-Porras JR; Nomdedeu B; Luño E; de Paz R; Such E; Tormo M; Vallespi T; Collado R; Xicoy B; Andreu R; Muñoz JA; Solé F; Cervera J; del Cañizo C;
Cancer; 2012 Jan; 118(1):127-33. PubMed ID: 21717439
[TBL] [Abstract][Full Text] [Related]
6. The der(1;7)(q10;p10) defining a distinct profile from -7/del(7q) in myelodysplastic syndromes: A systematic review and meta-analysis.
Lang W; Luo Y; Wang L; Zhang Y; Hu C; Wang H; Tong H
Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38164059
[TBL] [Abstract][Full Text] [Related]
7. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
[TBL] [Abstract][Full Text] [Related]
8. Leukemic transformation associated with massive hyperdiploidy in myelodysplastic syndrome (MDS) with der(1;7)(q10;p10): a novel case study.
Lim G; Oh SH; Choi JR; Lee HJ; Suh JT; Yoon HJ; Lee S; Lee WI; Park TS
Leuk Res; 2010 Aug; 34(8):e208-9. PubMed ID: 20299095
[No Abstract] [Full Text] [Related]
9. Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7.
Crisà E; Kulasekararaj AG; Adema V; Such E; Schanz J; Haase D; Shirneshan K; Best S; Mian SA; Kizilors A; Cervera J; Lea N; Ferrero D; Germing U; Hildebrandt B; Martínez ABV; Santini V; Sanz GF; Solé F; Mufti GJ
Leukemia; 2020 Sep; 34(9):2441-2450. PubMed ID: 32066866
[TBL] [Abstract][Full Text] [Related]
10. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications.
Hussain FT; Nguyen EP; Raza S; Knudson R; Pardanani A; Hanson CA; Van Dyke D; Tefferi A
Am J Hematol; 2012 Jul; 87(7):684-6. PubMed ID: 22565657
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic features in myelodysplastic syndromes.
Haase D
Ann Hematol; 2008 Jul; 87(7):515-26. PubMed ID: 18414863
[TBL] [Abstract][Full Text] [Related]
12. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
[TBL] [Abstract][Full Text] [Related]
14. Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10).
Hsiao HH; Sashida G; Ito Y; Kodama A; Fukutake K; Ohyashiki JH; Ohyashiki K
Cancer Genet Cytogenet; 2006 Mar; 165(2):161-6. PubMed ID: 16527611
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.
Mallo M; Luño E; Sanzo C; Cervera J; Haase D; Schanz J; García-Manero G; del Cañizo C; Sanz GF; Solé F
Leuk Res; 2011 Jun; 35(6):834-6. PubMed ID: 21269692
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.
El-Menoufy MAM; Mourad ZI; Farahat NM
J Egypt Natl Canc Inst; 2018 Dec; 30(4):133-138. PubMed ID: 30472199
[TBL] [Abstract][Full Text] [Related]
17. EVI1 expression predicts outcome in higher-risk myelodysplastic syndrome patients.
Liu L; Wang J; Jiang Y; Xie H; Tang X; Li Q; Wang H; Zou P; Miao Z; Lv Y; Wang H; Cao Z; Zhao Z
Leuk Lymphoma; 2018 Dec; 59(12):2929-2940. PubMed ID: 29846125
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities.
Pozdnyakova O; Miron PM; Tang G; Walter O; Raza A; Woda B; Wang SA
Cancer; 2008 Dec; 113(12):3331-40. PubMed ID: 18988232
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia.
de Souza Fernandez T; Ornellas MH; Otero de Carvalho L; Tabak D; Abdelhay E
Leuk Res; 2000 Oct; 24(10):839-48. PubMed ID: 10996202
[TBL] [Abstract][Full Text] [Related]
20. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X
Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
